Dan Cordeau of Spaulding & Slye represented MediSense in this lease transaction. David Provost served as Boston Properties in-house leasing representative. In a released statement, Provost says, "This lease reflects the desirability of our office campus in Bedford and the strength within the pharmaceutical and biotech market segments."
Demand for biotech space has increased in this area as the industry remains relatively safe from the high tech fallout. While Cambridge remains the center for the biotech and pharmaceutical industries on the east coast, its low vacancy rates for biotech space have pushed a number of companies to move out to the Greater Boston suburbs where appropriate facilities are being renovated for biotech use and the prices are cheaper.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
